HPV-positive status

HPV-positive status has been studied in 1 paper since 2016: 1 observational study in people. The newest paper, Nov 27, 2016: “Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on HPV-positive status

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“The HPV+ patients had better 5-year OS (57% vs 32%, P<.001) versus HPV- patients.”
Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without ChemotherapyInternational journal of radiation oncology, biology, physics2016doi:10.1016/j.ijrobp.2016.11.044
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Humans1

What is HPV-positive status linked with?

1

Studies link HPV-positive status with overall survival.

Overall survival

upin humans1HR 0.58

1 study
  1. HPV-positive status is associated with overall survival in humans (57% vs 32% 5-year overall survival; adjusted HR 0.58 (MVA-CCI)).

    Humansn = 231

Latest